Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

585 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD.
Ling Lundström M, Peterson C, Hedin CRH, Bergemalm D, Lampinen M, Magnusson MK, Keita ÅV, Kruse R, Lindqvist CM, Repsilber D, D'Amato M, Hjortswang H, Strid H; BIOIBD Consortium; Söderholm JD, Öhman L, Venge P, Halfvarson J, Carlson M. Ling Lundström M, et al. Among authors: venge p. Aliment Pharmacol Ther. 2024 Sep;60(6):765-777. doi: 10.1111/apt.18154. Epub 2024 Jul 12. Aliment Pharmacol Ther. 2024. PMID: 38997818
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease.
Ling Lundström M, Peterson C, Lampinen M, Hedin CRH, Keita ÅV, Kruse R, Magnusson MK, Lindqvist CM, Repsilber D, D'Amato M, Hjortswang H, Strid H, Rönnblom A, Söderholm JD, Öhman L, Venge P, Halfvarson J, Carlson M; BIOIBD consortium. Ling Lundström M, et al. Among authors: venge p. Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00605. doi: 10.14309/ctg.0000000000000605. Clin Transl Gastroenterol. 2023. PMID: 37256716 Free PMC article.
Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
Castro Tejera V, Öhman L, Aabakken L, Fellström B, Hausken T, Hovde Ø, Hreinsson JP, Lindberg G, Venge P, Simrén M, Törnblom H. Castro Tejera V, et al. Among authors: venge p. Aliment Pharmacol Ther. 2022 Sep;56(6):968-979. doi: 10.1111/apt.17182. Epub 2022 Aug 8. Aliment Pharmacol Ther. 2022. PMID: 35942522 Free PMC article.
585 results